ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Broker Notes
Analysts name 3 ASX shares to buy now
Broker Notes
Here's what top brokers say about the ResMed (ASX:RMD) share price forecast
Growth Shares
These ASX growth shares could be strong buys
Share Market News
Here are the top 10 ASX shares today
Growth Shares
3 buy-rated ASX shares with strong growth potential
Healthcare Shares
ResMed (ASX:RMD) share price edges higher despite going ex-dividend
Dividend Investing
These 6 ASX shares are going ex-dividend this week
Growth Shares
10 top ASX shares to buy in November
Share Market News
3 outstanding ASX growth shares to buy now
Broker Notes
Top broker names 2 of the best ASX share ideas for November
Share Fallers
Why Advanced Human Imaging, ResMed, Western Areas, and Westpac are falling
Broker Notes
Leading brokers name 3 ASX shares to buy today
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
